| Naside Gözde Durmuş | |
| Birth Place: | Izmir, Turkey |
| Workplaces: | Stanford University |
Naside Gözde Durmuş (born 1985, Izmir) is a Turkish scientist and geneticist. She is currently Assistant Professor of Radiology at Stanford University. Her research focuses on nanotechnology and micro-technology applications on current world-threatening health issues, like cancer and antibiotic resistance. In 2015, MIT Technology Review listed her under the category of pioneers in the magazine's list of 35 Innovators Under 35.[1]
Durmuş was born in 1985 in Izmir, Turkey.[2] In 2003, she started her undergraduate studies at the Middle East Technical University, specializing in Molecular Biology and Genetics. Later on, she obtained a Fulbright scholarship and moved to the United States to pursue higher education, achieving a Masters in Engineering from Boston University in 2009, and receiving a Ph.D. degree in Biomedical Engineering from Brown University in May 2013.[3]
Durmus is currently an Assistant Professor at Stanford University. In 2014, she took a position as a post-doctoral researcher at Stanford. She conducted her postdoctoral research with Ronald W. Davis at the Stanford University Genome Technology Center and Stanford University School of Medicine.[4] In 2015, she has been recognized among the "Top 35 Innovators Under 35" (TR35), as a pioneer in biotechnology and medicine, by MIT Technology Review Magazine.
Her work focuses on developing low-cost nanotechnology tools that can be used for the diagnose and treatment of diseases, like for instance a fast method for detecting the physical features of a cell, by having them levitate in a magnetic field, this being able to measure in a shorter period of time how a microbe responds to a certain drug,[1] and making it possible to differentiate cancerous cells from healthy ones.[5]